You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 205031 - 205040 of 207712 results
  1. NOVEL PUMP FOR TIDAL FLOW EXTRACORPOREAL SUPPORT

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (Unedited Applicant's Abstract):Extracorporeal Circulation is used in several blood treatment applications, including hemodialysis, respiratory support, and blood warming/cooling. These procedures usually require two vascular access sites; one for draining blood and the other returning treated blood. The blood treatment applications can also be performe ...

    SBIR Phase II 2001 Department of Health and Human ServicesNational Institutes of Health
  2. NOVEL PUMP FOR TIDAL FLOW EXTRACORPOREAL SUPPORT

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (Unedited Applicant's Abstract):Extracorporeal Circulation is used in several blood treatment applications, including hemodialysis, respiratory support, and blood warming/cooling. These procedures usually require two vascular access sites; one for draining blood and the other returning treated blood. The blood treatment applications can also be performe ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  3. Paracorporeal Artificial Lung Development

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (Verbatim from the Applicant's Abstract): Despite the widespread success and enthusiasm f single and double lung transplantation, demand for donor lungs has steadily outgrown supply. Currently, the average wait is two years, with 30 percent wait-list mortality. A prototype Paracorporeal Artificial Lung (PAL) was designed and built by MC3 (Ann Arb ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  4. Variable compliance chamber to alter pulmonary impedance

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (Applicant's Abstract): A variable compliance chamber (VCC) is proposed that will maintain near normal pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work (steady and pulsatile) that the right heart must pump against, and it is altered (primarily in the form of decreased compliance) in p ...

    SBIR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  5. VARIABLE COMPLIANCE CHAMBER TO ALTER PULMONARY IMPEDANCE

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A variable compliance chamber (VCC) is proposed to control pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work the right heart must pump against, and it is altered (primarily in the form of decreased compliance) in pulmonary disease and in the implantation of oxygenation assisted devices; this i ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. AMBULATORY ARTERIOVENOUS CARBON DIOXIDE REMOVAL

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Chronic Obstructive Pulmonary Disease (COPD) affects 15-17 million people in the United States and is the fourth leading cause of death in the U.S. When COPD reaches end-stage, hypercarbia, not hypoxia, usually limits the COPD patients' ability to ambulate. Lung Volume Reduction Surgery remains investigational. Lung transplantation is available to only 900/yea ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. Ambulatory Arteriovenous Carbon Dioxide Removal

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): End-stage lung disease from COPD, cystic fibrosis, primary pulmonary hypertension, and ideopathic pulmonary fibrosis affects 15-17 million people in the United States and is the fourth leading cause of death in the U.S. With end-stage lung disease, carbon dioxide retention is a common and grave prognostic sign with limited treatment options. Long-term ventilato ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Simplified Total Liquid Ventilator

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The acute respiratory distress syndrome (ARDS) is a severe, life-threatening disease process that affects approximately 150,000 patients per year with an associated 30-40% mortality rate. Clinical studies are currently exploring the safety and effectiveness of Partial Liquid Ventilation (PLV), in which a perfluorocarbon-filled lung is gas-ventilated, in the ...

    STTR Phase II 2004 Department of Health and Human ServicesNational Institutes of Health
  9. SIMPLIFIED TOTAL LIQUID VENTILATOR

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    The acute respiratory distress syndrome (ARDS) is a severe, life-threatening disease process, which affects approximately 150,000 patients per year with an associated 30-50 percent mortality rate. Periluorocarbons are inert, colorless, low surface tension liquids that can carry large quantities of oxygen and carbon dioxide. Clinical studies are currently exploring the safety and effectiv ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  10. VARIABLE COMPLIANCE CHAMBER TO ALTER PULMONARY IMPEDANCE

    SBC: MICHIGAN CRITICAL CARE CONSULTANTS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A variable compliance chamber (VCC) is proposed to control pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work the right heart must pump against, and it is altered (primarily in the form of decreased compliance) in pulmonary disease and in the implantation of oxygenation assisted devices; this i ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government